244 related articles for article (PubMed ID: 10188780)
1. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
2. The (S)-(+)-enantiomer of dimethindene: a novel M2-selective muscarinic receptor antagonist.
Pfaff O; Hildebrandt C; Waelbroeck M; Hou X; Moser U; Mutschler E; Lambrecht G
Eur J Pharmacol; 1995 Nov; 286(3):229-40. PubMed ID: 8608784
[TBL] [Abstract][Full Text] [Related]
3. New functionally selective muscarinic agonists.
Lambrecht G; Moser U; Grimm U; Pfaff O; Hermanni U; Hildebrandt C; Waelbroeck M; Christophe J; Mutschler E
Life Sci; 1993; 52(5-6):481-8. PubMed ID: 7680092
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
5. Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Jul; 35(15):2787-98. PubMed ID: 1379640
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
Davies RH; Scholes HE; Virdi S; Broadley KJ
J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
[TBL] [Abstract][Full Text] [Related]
8. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
9. The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists.
Melchiorre C; Minarini A; Budriesi R; Chiarini A; Spampinato S; Tumiatti V
Life Sci; 1995; 56(11-12):837-44. PubMed ID: 10188783
[TBL] [Abstract][Full Text] [Related]
10. Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors?
Eltze M; König H; Ullrich B; Grebe T
Eur J Pharmacol; 1997 Jul; 332(1):77-87. PubMed ID: 9298928
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists.
Wallis RM
Life Sci; 1995; 56(11-12):861-8. PubMed ID: 10188786
[TBL] [Abstract][Full Text] [Related]
14. Glycopyrronium bromide blocks differentially responses mediated by muscarinic receptor subtypes.
Fuder H; Meincke M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):591-5. PubMed ID: 7689704
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
Hamrouni AM; Gudka N; Broadley KJ
Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors.
Chiarini A; Budriesi R; Bolognesi ML; Minarini A; Melchiorre C
Br J Pharmacol; 1995 Apr; 114(7):1507-17. PubMed ID: 7606355
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
Minarini A; Bolognesi ML; Budriesi R; Canossa M; Chiarini A; Spampinato S; Melchiorre C
J Med Chem; 1994 Sep; 37(20):3363-72. PubMed ID: 7932564
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of a novel, potent and selective M3 antagonist.
Ghelardini C; Bartolini A; Galeotti N; Bellucci C; Dei S; Gualtieri F
Life Sci; 1997; 61(13):1217-26. PubMed ID: 9324063
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of zamifenacin at muscarinic receptors in vitro.
Watson N; Reddy H; Stefanich E; Eglen RM
Eur J Pharmacol; 1995 Oct; 285(2):135-42. PubMed ID: 8566131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
